Biblio
Hepatocyte growth factor pretreatment boosts functional recovery after spinal cord injury through human iPSC-derived neural stem/progenitor cell transplantation. Inflamm Regen. 2023;43(1):50.
Human-induced pluripotent stem cell-derived neural stem/progenitor cell ex vivo gene therapy with synaptic organizer CPTX for spinal cord injury. Stem Cell Reports. 2024.
Laying the groundwork for a first-in-human study of an iPSC-based intervention for spinal cord injury. Stem Cells. 2018.
Long-term selective stimulation of transplanted neural stem/progenitor cells for spinal cord injury improves locomotor function. Cell Rep. 2021;37(8):110019.
Mesenchymal properties of iPSC-derived neural progenitors that generate undesired grafts after transplantation. Commun Biol. 2023;6(1):611.
Modulation by DREADD reveals the therapeutic effect of human iPSC-derived neuronal activity on functional recovery after spinal cord injury. Stem Cell Reports. 2022;17(1):127-142.